Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes
Nathaniel B. Gunter(Mayo Clinic in Florida), Clifford R. Jack(Mayo Clinic), Jonathan Graff‐Radford(Mayo Clinic), Vijay K. Ramanan(Mayo Clinic in Arizona), Michael G. Heckman(Mayo Clinic in Florida), Prashanthi Vemuri(Mayo Clinic in Arizona), Ronald C. Petersen(Mayo Clinic in Arizona), Robel K Gebre(Mayo Clinic), David S. Knopman(Mayo Clinic), Val J. Lowe(Mayo Clinic), Owen A. Ross(Jacksonville College)
Cited by 16
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k